Design, synthesis and anti-cancer evaluation of genistein-1,3,5-triazine derivatives
作者:Jing-Pei Zou、Zhen Zhang、Jin-Yu Lv、Xiao-Qing Zhang、Zhao-Yuan Zhang、Shu-Tong Han、Yu-Wei Liu、Wei-Wei Liu、Jing Ji、Da-Hua Shi
DOI:10.1016/j.tet.2023.133293
日期:2023.3
MTT assay. Most genistein-1,3,5-triazine derivatives showed better anti-cancer activity than nuclear parent genistein. Compound 4i displayed the strongest antiproliferative activity against MDA-MB-231 cells (IC50 = 23.13 μM), which was better than 5-fluorouracil (IC50 = 78.04 μM). Further studies showed that compound 4i not only could inhibit the migration, invasion and adhesion of MDA-MB-231 cells, but
通过亲核取代合成了12个染料木黄酮-1,3,5-三嗪衍生物,并通过1 H NMR、13 C NMR、IR、HR-MS和单晶X射线衍射对其进行了表征。HPLC测定目标化合物纯度在99%以上。这些化合物对 MDA-MB-231(乳腺癌)、HeLa(宫颈癌)、HCT-116(前列腺癌)和 Huh-7(肝癌)癌细胞系的抗增殖活性通过 MTT 测定法进行评估。大多数染料木黄酮-1,3,5-三嗪衍生物显示出比核母体染料木黄酮更好的抗癌活性。化合物4i对 MDA-MB-231 细胞显示出最强的抗增殖活性 (IC 50 = 23.13 μM),优于 5-氟尿嘧啶 (IC 50 = 78.04 μM)。进一步研究表明,化合物4i不仅可以抑制MDA-MB-231细胞的迁移、侵袭和粘附,而且对体内MDA-MB-231肿瘤异种移植物的增殖也有很大的抑制作用。此外,ADME 特性和毒性预测表明这些化合物可能具有成